1. Increased expression of type 1 cannabinoid (CB1) receptor among patients with rotator cuff lesions and shoulder stiffness
   Shu-Jui Kuo et al, 2017, Journal of Shoulder and Elbow Surgery CrossRef
2. Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery
   Alicia Bort et al, 2017, Mol Pain CrossRef
3. Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression
   Ming Tang et al, 2018, Cell Death Dis CrossRef
4. Cannabinoids for the treatment of rheumatic diseases — where do we stand?
   Daphna Katz-Talmor et al, 2018, Nat Rev Rheumatol CrossRef
5. Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages
   Yu Du et al, 2018, J Inflamm CrossRef
6. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
   Kinga Tóth et al, 2019, Molecules CrossRef
7. Wound healing potential of selected Southern African medicinal plants: a review
   Constance Chingwaru et al, 2019, Journal of Herbal Medicine CrossRef
8. Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing
   Natalia Murataeva et al, 2019, Experimental Eye Research CrossRef
9. Transforming growth factor beta (TGF-β) activity in immuno-oncology studies
   Gabriel Gallo-Oller et al, 2019 CrossRef
10. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Piercarlo Sarzi-Puttini et al, 2019, Expert Review of Clinical Immunology CrossRef
11. Beta-caryophyllene enhances wound healing through multiple routes
    Sachiko Koyama et al, 2019, PLoS ONE CrossRef
12. 2‐arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions
    Ana Feliu et al, 2020, Glia CrossRef
13. Effects of topical treatment of cannabidiol extract in a unique manuka factor 5 manuka honey carrier on second intention wound healing on equine distal limb wounds: a preliminary study
    VC McIver et al, 2020, Aust Vet J CrossRef
14. Translational Neuroendocrinology of Human Skin: Concepts and Perspectives
    Yuval Ramot et al, 2020, Trends in Molecular Medicine CrossRef
15. The therapeutic potential of cannabinoids for integumentary wound management
    Maximillian A. Weigelt et al, 2020, Exp Dermatol CrossRef
16. Cannabinoids in dermatologic surgery
    Ha Eun Kong et al, 2021, Journal of the American Academy of Dermatology CrossRef
17. Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis
    You Li et al, 2020, Aging CrossRef
18. Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction
    Battistina Asproni et al, 2021, Molecules CrossRef
19. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
    Newman Osafo et al, 2021, Mol Biol Rep CrossRef
20. An enzyme-responsive Gp1a-hydrogel for skin wound healing
    Chunming Zhao et al, 2021, J Biomater Appl CrossRef
21. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
    Hebaallah Mamdouh Hashiesh et al, 2021, Front. Pharmacol. CrossRef
22. Genetic deletion of the cannabinoid receptors CB1 and CB2 enhances inflammation with diverging effects on skin wound healing in mice
    Tim Ruhl et al, 2021, Life Sciences CrossRef
23. Skin, Lung, Eyes, and Hair
    Julie Wendt et al, 2021 CrossRef
24. Acute and long-term effects of cannabinoids on hypertension and kidney injury
    Daria Golosova et al, 2022, Sci Rep CrossRef
25. Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management
    Berhanu Geresu Kibret et al, 2022, Adv Skin Wound Care CrossRef
26. Cannabidiol Improves Random-Pattern Skin Flap Survival in Rats: Involvement of Cannabinoid Type-2 Receptors
    Armin Aryannejad et al, 2022, J Reconstr Microsurg CrossRef
27. Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis
    Tao Liu et al, 2022, J Transl Med CrossRef
28. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
    Robert Ramer et al, 2022, Cells CrossRef
29. Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor β pathway in monocrotaline-induced pulmonary hypertension in rats
    Anna Krzyżewska et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
30. Applications to wound healing: Cannabinoid receptor 1 antagonism and collagen deposition
    Inês Correia-Sá, 2023 CrossRef
31. The effect of cannabinoids on wound healing: A review
    Aniruddha C. Parikh et al, 2024, Health Science Reports CrossRef
32. Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence
    Dhakshila Niyangoda et al, 2024, Pharmaceutics CrossRef
33. Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis
    Lujain Bader Eddin et al, 2024, Pharmacology Res & Perspec CrossRef
34. Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis-BCG by inhibiting NF-κB signaling
    Jessica Do Prado Valeriano et al, 2024 CrossRef